Clinicians

WHY TEST?

Biological changes in the brain can begin decades before symptoms appear

Blood-based biomarkers can provide measurable information about biological processes associated with Alzheimer's disease and neurodegeneration.

Rather than relying on a single measurement, our testing combines multiple brain biomarkers to give clinicians a broader view of a patient's underlying biology.

Testing can help your patients establish a brain health baseline, gain early insights, and track changes over time, helping get a head start on personalized prevention strategies within the context of the patient's complete clinical picture.

PARTNER WITH US

Interested in offering
testing to your patients?

Tell us about your practice and a member of our clinical partnerships team will reach out.

Flexible volume tiers

Testing capacity designed to fit your practice, from individual clinicians to larger groups.

Clinical education resources

Access to webinars, guides, and peer literature to support confident ordering.

Dedicated clinical education support

We have a dedicated team of clinicians specially trained in brain biomarker interpretation who will meet regularly to discuss cases and answer questions from ordering providers at your practice.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

By submitting, you agree to our privacy policy. AlzLabs testing is ordered through and supported by RetainHealth.

TESTING PORTFOLIO

Comprehensive Biomarker Testing

Go beyond a single brain biomarker.
Panels are customized for each patient (see example tests below from our >75 biomarkers offered).
Our panel evaluates multiple biomarkers associated with cognitive decline, providing additional context that a single biomarker alone cannot provide.

⬤ Brain Health Panel

Emerging blood-based biomarkers for neurodegeneration risk stratification.

⬤ pTau-217

⬤ pTau-217/Beta-Amyloid 42 ratio

⬤ pTau-181

⬤ pTau-181/Beta-Amyloid 42 ratio

⬤ Beta-Amyloid 42/40 ratio

⬤ Glial fibrillary acidic protein (GFAP)

⬤ Neurofilament light (NfL)

⬤ ApoE4 protein expression

⬤ ApoE ratio

*New proprietary marker R&D coming soon (e.g., Alpha-synuclein protein & ratios)

⬤ Genetic Risk Panel

Inherited risk factors for neurodegeneration, methylation, and cognitive metabolism.

⬤ APOE

⬤ MTHFR

⬤ KLOTHO

⬤ Cardiometabolic Panel

Vascular and metabolic markers with strong brain health implications.

⬤ Lipoprotein(a) (Lp(a))

⬤ ApoB

⬤ Total Cholesterol

⬤ HOMA-IR

⬤ HbA1c

⬤ Desmosterol

⬤ Hormone Panel

Hormones with significant influence on cognition and neurological function.

⬤ Free testosterone

⬤ Estradiol (E2)

⬤ Progesterone

⬤ DHEA-S

⬤ Thyroid panel

⬤ Cortisol

⬤ Inflammation Panel

Systemic and neuroinflammatory markers central to chronic disease risk.

⬤ High-sensitivity CRP (hsCRP)

⬤ Fibrinogen

⬤ Lp-PLA2

⬤ Nutrition Panel

Nutritional markers with significant influence on brain health, cognition, and neurological function.

⬤ Omega-3 fatty acids

⬤ Omega-6 fatty acids

⬤ Vitamin D

⬤ Vitamin B12

⬤ Trans fats

⬤ Monounsaturated fats

WHY ALZLABS?
Our research and laboratory partner

Diagnostic quality at every stage

Comprehensive Panels

Multi-domain biomarker testing for brain health, including genetics, cardiometabolic, nutrition, hormone, and inflammation

Brain Biomarkers

We have clinically validated a proprietary precision blood-based biomarker panel for neurological health assessment

Analytical Rigor

CLIA-certified processing with robust QC protocols, validated reference ranges; delta reporting also tracks changes over time

Sample Handling

Cold-chain logistics, pre-validated collection kits, chain-of-custody documentation to ensure sample integrity from draw to result

Clinical Reporting

Physician-curated reports with clinical context, interpretation guidance, reference comparators, and follow-up considerations

Practice Support

Dedicated clinical support team, ordering portal, bespoke EMR, patient communication templates, and staff onboarding resources

For Clinicians

Expand your clinical toolkitwith brain biomarkers